Immuneering (IMRX) Other Working Capital Changes (2020 - 2026)
Immuneering's (IMRX) quarterly Other Working Capital Changes came in at -$94221.0 in Q1 2026, down 17.57% year-on-year from -$114307.0 in Q1 2025, and down 2.52% quarter-over-quarter from -$91904.0 in Q4 2025.
Immuneering (IMRX) Other Working Capital Changes (2020 - 2026) Analysis & Trends
Immuneering's Other Working Capital Changes history runs 7 years deep, the most recent figure standing at -$94221.0 for Q1 2026.
- On a quarterly basis, Other Working Capital Changes fell 17.57% year-over-year to -$94221.0 in Q1 2026; TTM through Mar 2026 was -$352514.0, a 18.08% decrease from a year earlier, with the FY2025 full-year figure at -$338432.0, down 12.77% from the prior year.
- Other Working Capital Changes eased to -$94221.0 in Q1 2026 per IMRX's latest filing, from -$91904.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $1.4 million in Q2 2022 and bottomed at -$1.5 million in Q2 2025.
- The 5-year median for Other Working Capital Changes is $4083.0 (2022), against an average of -$13826.7.
- Across the five-year window, Other Working Capital Changes soared 60.59% in 2022 and plunged 724.65% in 2023, its largest moves.
- Year by year, Other Working Capital Changes stood at -$9664.0 in 2022, then slumped by 724.65% to -$79694.0 in 2023, then increased by 1.91% to -$78168.0 in 2024, then decreased by 17.57% to -$91904.0 in 2025, then slipped by 2.52% to -$94221.0 in 2026.
- Per Business Quant, the three latest IMRX Other Working Capital Changes figures stand at -$94221.0 (Q1 2026), -$91904.0 (Q4 2025), and -$84230.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Immuneering | 279.33 Mn | 279.33 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -94,221.00 |
| Mar 31, 2026 | -94,221.00 |
| Mar 31, 2026 | -94,221.00 |
| Dec 31, 2025 | -91,904.00 |
| Dec 31, 2025 | -91,904.00 |
| Dec 31, 2025 | -91,904.00 |
| Sep 30, 2025 | -84,230.00 |
| Sep 30, 2025 | -84,230.00 |
| Sep 30, 2025 | -84,230.00 |
| Jun 30, 2025 | -82,159.00 |
| Jun 30, 2025 | -82,159.00 |
| Jun 30, 2025 | -82,159.00 |
| Mar 31, 2025 | -80,139.00 |
| Mar 31, 2025 | -80,139.00 |
| Mar 31, 2025 | -80,139.00 |
| Dec 31, 2024 | -78,168.00 |
| Dec 31, 2024 | -78,168.00 |
| Dec 31, 2024 | -78,168.00 |
| Sep 30, 2024 | -70,988.00 |
| Sep 30, 2024 | -70,988.00 |